ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan · Delayed Price · Currency is TWD 20.00
+0.10 (0.50%)
Oct 30, 2026, 1:30 PM CST
ScinoPharm Taiwan Market Cap
ScinoPharm Taiwan has a market cap or net worth of 15.81 billion as of October 30, 2026. It is the 14,636th most valuable company in the world and the 502nd biggest in Taiwan. Its market cap has increased by 12.04% in one year.
Market Cap
15.81B
Enterprise Value
13.19B
Revenue
3.07B
Global Rank
Country Rank
#502 Taiwan
PE Ratio
419.18
ChartMarket Cap Chart
Since October 29, 2010, ScinoPharm Taiwan's market cap has decreased from 30.44B to 15.81B, a decrease of -48.04%. That is a compound annual growth rate of -4.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 15.81B | 19.40% |
| Dec 31, 2025 | 13.24B | -24.04% |
| Dec 31, 2024 | 17.44B | -16.48% |
| Dec 29, 2023 | 20.88B | 3.73% |
| Dec 30, 2022 | 20.12B | 3.25% |
| Dec 30, 2021 | 19.49B | -14.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 23.22B |
| Handa Pharmaceuticals | 22.35B |
| TTY Biopharm Company | 19.99B |
| YungShin Global Holding | 15.93B |
| Synmosa Biopharma | 15.67B |
| Grape King Bio | 12.37B |
| Foresee Pharmaceuticals | 11.94B |
| Standard Chemical & Pharmaceutical | 10.17B |